Furthermore, there is now accumulating evidence from preclinical studies that the autonomous islet ECS is a key player in obesity-induced inflammation in islets, and β-cell damage and apoptosis from many causes can be mitigated by CB1R blockers. The gene discussed is CNR1; the disease is obesity due to melanocortin 4 receptor deficiency.